Treatment issues in spontaneous cervicocephalic artery dissections

Area of Science:

• Neurology
• Vascular Surgery
• Internal Medicine

Background:

• Cervicocephalic arterial dissections present complex management challenges.
• Key issues include acute stroke treatment, stroke prevention in local presentations, and post-dissection care duration.
• Debates persist regarding optimal antithrombotic therapy (anticoagulants vs. aspirin) and the role of angioplasty/stenting.

Purpose of the Study:

• To review the current understanding and unresolved issues in managing cervicocephalic arterial dissections.
• To highlight the need for evidence-based guidelines for acute and long-term patient care.
• To discuss the challenges in conducting randomized clinical trials for this condition.

Main Methods:

• Review of existing literature and clinical consensus on cervicocephalic arterial dissections.
• Discussion of therapeutic options including antithrombotic agents and interventional procedures.
• Exploration of clinical decision-making in the absence of definitive trial data.

Main Results:

• Urgent antithrombotic treatment is generally agreed upon for recent nonhemorrhagic dissections due to thromboembolic risk.
• The choice between anticoagulants and aspirin, and the utility of angioplasty/stenting, remain subjects of ongoing debate.
• No definitive evidence from randomized trials currently guides all management decisions.

Conclusions:

• Management requires a case-by-case approach, emphasizing clinical judgment.
• A stepped care strategy is advised for patients who do not improve with initial treatment.
• Further research, potentially through well-designed clinical trials, is needed to resolve management uncertainties.